Login / Signup

Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.

Matthew J PriceRichard A ShlofmitzDouglas J SpriggsThomas A HaldisPaul MyersAlexandra Popma AlmonacidAkiko MaeharaMichelle DaulerYun PengRoxana Mehran
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
In-stent late lumen loss is non-inferior, and appears to be superior, with the thin-strut novel composite wire R-Onyx DES compared with Resolute DES. Continued evolution of stent design can improve angiographic outcomes in complex lesions, even in the current era of next-generation DES.
Keyphrases
  • clinical trial
  • study protocol
  • phase iii
  • type diabetes